Companies /Healthcare

Taysha Gene Therapies Inc

NASDAQ: TSHA Biotechnology
$5.02
▼ $0.14 (−2.71%) today
Markets closed · 2:19pm ET
Today · % change

Fundamentals

Market Cap
$1.6B
Revenue (TTM)
$5.5M
EPS (TTM)
$-0.41
52-Week Range
$3 – $7
Street Target
$13.33

About Taysha Gene Therapies

Taysha Gene Therapies Inc is a pioneering firm based in Dallas, Texas, dedicated to advancing gene therapy. The company specializes in creating innovative treatments for rare diseases of the central nervous system using adeno-associated virus technology. Its portfolio includes promising therapies for conditions like giant axonal neuropathy, Rett syndrome, and various forms of Batten disease. Taysha Gene Therapies works closely with The University of Texas Southwestern Medical Center, aiming to transform the lives of patients with monogenic diseases through cutting-edge gene therapy solutions.

TSHA Coverage

10:26am ET
Investing

3 Penny Stocks to Buy With $100

Have you thought about adding penny stocks to your portfolio? You may be onto something. That is, as long as you choose the right stock picks. But there are risks to consider too.…

Joshua Rodriguez